[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology].
- DOI
- 10.1016/j.bulcan.2025.04.006
- Published
- 2025 Sep
- Container
- Bulletin du cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bulcan.2025.04.006,
title = {[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology].},
author = {Berlanga P and Pasqualini C and Gambart M and Dumont B and Thebaud E and Tandonnet J and Benadiba J and Leruste A and Coze C and Schleiermacher G and Defachelles AS},
year = {2025},
journal = {Bulletin du cancer},
doi = {10.1016/j.bulcan.2025.04.006},
url = {https://doi.org/10.1016/j.bulcan.2025.04.006}
}RIS
TY - JOUR TI - [Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology]. AU - Berlanga P AU - Pasqualini C AU - Gambart M AU - Dumont B AU - Thebaud E AU - Tandonnet J AU - Benadiba J AU - Leruste A AU - Coze C AU - Schleiermacher G AU - Defachelles AS PY - 2025 JO - Bulletin du cancer DO - 10.1016/j.bulcan.2025.04.006 UR - https://doi.org/10.1016/j.bulcan.2025.04.006 ER -
APA
P, B., C, P., M, G., B, D., E, T., J, T., J, B., A, L., C, C., G, S., & AS, D. (2025). [Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2025.04.006
Source records
- pubmed · retrieved 2026-09-27T09:41:06.707Z